About Dr. Mei

Dr. Kuo-Ching (KC) Mei is an Assistant Professor of Molecular Pharmaceutics at the University of Utah College of Pharmacy. A trained pharmacist from Taiwan, he brings integrated experience from the pharmaceutical industry, international doctoral training, and academic research to the development of next-generation therapeutic delivery systems.

Dr. Mei earned his BS in Pharmacy and pharmacist licensure in Taiwan and worked for three years in the pharmaceutical industry as a formulation scientist specializing in complex controlled-release dosage forms. He received his PhD in Pharmaceutical Science with a focus on Pharmaceutics from King’s College London, followed by postdoctoral research at the UCLA David Geffen School of Medicine and the UNC Eshelman School of Pharmacy, where he specialized in immunoengineering and biotherapeutic delivery. Before joining the Department of Molecular Pharmaceutics at the University of Utah in 2025, he served as a tenure-track faculty member at the SUNY Binghamton School of Pharmacy and Pharmaceutical Sciences.

His laboratory focuses on lipid nanoparticle (LNP) synthesis, formulation, and molecular engineering for nucleic acid delivery, with applications in cancer immunotherapy and gene therapy for rare diseases. His research is supported by the National Institutes of Health, including a 2024 NIGMS R35 MIRA Award for Early Stage Investigators focused on developing biotherapeutic delivery strategies for immune modulation to advance gene delivery & therapy. His laboratory is also affiliated with the NCI-designated Huntsman Cancer Institute’s Experimental Therapeutics Program in developing novel cancer therapeutics.

Dr. Mei is committed to training future scientists and advancing delivery technologies that improve the safety, specificity, and translational potential of modern biotherapeutics.